Investigation of Uric Acid and Cystatin C on Low-Carbohydrate Diet (LCD)

Crossmark: check for updates

Authors

  • Hiroshi Bando Tokushima University and Medical Research, Tokushima, Japan
  • Koji Ebe Takao Hospital, Kyoto, Japan
  • Tetsuo Muneta Muneta Maternity Clinic, Chiba, Japan
  • Masahiro Bando Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
  • Yoshikazu Yonei Anti-Aging Medical Research Center, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, Japan

DOI:

https://doi.org/10.17140/DROJ-3-133

Keywords:

Low-carbohydrate diet (LCD), Morbus value (M-value), Cystatin C Creatinine, Type 2 diabetes mellitus (T2DM)

Abstract

Background: As to nutritional therapy, continuous discussions were observed concerning calorie restriction (CR) and low-carbohydrate diet (LCD). Authors and colleagues have applied LCD for lots of diabetic patients and reported the detail relationship with ketone bodies and Morbus (M) value. Methods: Ninety-three patients with type 2 diabetes mellitus (T2DM) were considered as subjects in the study, among which 41 were male and 52 were female, 58.3±13.2 years old on average, 60 years old in median. Methods were as follows: 1) patients were admitted and provided formular diet, which included CR diet (60% carbohydrates, 1400 kcal/day) on day 1-2, and LCD (12% carbohydrate, 1400 kcal/day) on day 3-14; 2) several biomarkers on fasting were measured on day 2, 4 and 14; 3) daily profile of blood glucose were done on day 2 and day 4. Results: According to the M-value, subjects were classified into 4 groups, which were less than 25, 26-100, 101-250, more than 251, and number was 24, 24, 24, 21, respectively. The average HbA1c in 4 groups were 6.6%, 7.4%, 8.5% and 9.5% respectively. The median M-values decreased from day 2 to 4, which were 10.4 to 9.1, 53.5 to 7.7, 150 to 19.1 and 438 to 87, respectively. The average uric acid in each group revealed significant increase from day 2 to day 14. There were significant correlation between uric acid increment and creatinine increment, and among creatinine, creatinine clearance (CCr) and Cystatin C. Conclusion: LCD showed efficacy for glucose variability with significant decrease in glucose and M-value. Renal study showed increase of serum uric acid. In addition to correlations of Cystatin C and biomarkers, current results would be from some dehydrated state and/or relative decrease of total calorie intake. These findings would become the fundamental data of efficacy of LCD and its physiological influences for renal function.

References

Feinman RD, Pogozelski WK, Astrup A, et al. Dietary carbo-hydrate restriction asthe first approach in diabetes management: Critical review and evidence base. Nutrition. 2015; 31(1): 1-13. doi: 10.1016/j.nut.2014.06.011

Westman EC, Vernon MC. Has carbohydrate-restriction been forgotten as atreatment for diabetes mellitus? A perspective on the ACCORD study design. Nutr Metab (Lond). 2008; 5: 10. doi: 10.1186/1743-7075-5-10

Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. N Engl J Med. 2008; 359: 229-241. doi: 10.1056/NEJMoa0708681

Accurso A, Bernstein RK, Dahlqvist A, et al. Dietary carbo-hydrate restriction in type 2 diabetes mellitus and metabolic syn-drome: time for a critical appraisal. Nutr Metab (Lond). 2008; 5: 9. doi: 10.1186/1743-7075-5-9

Schwarzfuchs D, Golan R, Shai I. Four-year follow-up after two-year dietary interventions. N Engl J Med. 2012; 367: 1373- 1374. doi: 10.1056/NEJMc1204792

Atallah R, Filion KB, Wakil SM. Long-term effects of 4 popu-lar diets on weight loss and cardiovascular risk factors: A sys-tematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2014; 7(6): 815-827. doi: 10.1161/CIRCOUT-COMES.113.000723

McVay MA, Voils CI, Coffman CJ, et al. Factors associated with choice of a low-fat or low-carbohydrate diet during a be-havioral weight loss intervention. Appetite. 2014; 83: 117-124. doi: 10.1016/j.appet.2014.08.023

Gow ML, Garnett SP, Baur LA, Lister NB. The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth. Nutrients. 2016; 8(8). pii: E486. doi: 10.3390/nu8080486

Ebe K, Ebe Y, Yokota S, et al. Low Carbohydrate diet (LCD) treated for three cases as diabetic diet therapy. Asia Pac Fam Med. 2004; 51: 125-129.

Bando H, Nakamura T. Carbo-count therapy and low car-bohydrate diet (LCD). The Journal of the Therapy. 2008; 90: 3105-3111.

Bando H, Ebe K, Nakamura T, Bando M, Yonei Y. Low car-bohydrate diet (LCD): Long- and short-term effects and hyper-ketonemia. Glycative Stress Research. 2016; 3(4): 193-204. Web site. http://www.toukastress.jp/webj/article/2016/GS16-18.pdf. Accessed June 27, 2017.

Bando H, Ebe K, Muneta T, Bando M, Yonei Y. Effect of low carbohydrate diet on type 2 diabetic patients and usefulness of M-value. Diabetes Res Open J. 2017; 3(1): 9-16. doi: 10.17140/ DROJ-3-130

Bando H, Ebe K, Muneta T, Bando M, Yonei Y. Clinical ef-fect of low carbohydrate diet (LCD): Case report. Diabetes Case Rep. 2017; 2: 124. doi: 10.4172/2572-5629.1000124

Muneta T, Kawaguchi E, Nagai Y, et al. Ketone body eleva-tion in placenta, umbilical cord, newborn and mother in normal delivery. Glycative Stress Research. 2016; 3(3): 133-140. Web site. http://www.toukastress.jp/webj/article/2016/GS16-10.pdf. Accessed June 27, 2017.

Schlichtkrull J, Munck O, Jersild M. The M-value, an index of blood sugar control in diabetics. Acta Med Scand. 1965; 177: 95-102. doi: 10.1111/j.0954-6820.1965.tb01810.x

Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gate-wood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970; 19: 644-655. doi: 10.2337/diab.19.9.644

Siegelaar SE, Holleman F, Hoekstra JBL, Devries JH. Glu-cose variability; does it matter? Endocr Rev. 2010; 31(2): 171- 182. doi: 10.1210/er.2009-0021

Yanai H. 4 steps Excel Statistics. 3rd ed. Tokorozawa, Japan: Seiunsha Publishing Co. Ltd.; 2014.

Bernstein RK. Dr. Bernstein’s DiabetesSolution: The Com-plete Guide to Achieving Normal Blood Sugars. New York, USA: Little, Brown US; 2011.

Atkins RC. Dr Atkins’ New Diet Revolution. New York, USA: Harper-Collins; 2001.

Hu T, Yao L, Reynolds K, et al. The effects of a low-carbohy-drate diet vs. a low-fat diet on novel cardiovascular risk factors: A randomized controlled trial. Nutrients. 2015; 7(9): 7978-7994. doi: 10.3390/nu7095377

Chen JH, Ouyang C, Ding Q, Song J, Cao W, Mao L. A mod-erate low-carbohydrate low-calorie diet improves lipid profile, insulin sensitivity and adiponectin expression in rats. Nutrients. 2015; 7: 4724-4738. doi: 10.3390/nu7064724

Saslow LR, Kim S, Daubenmier JJ, et al. A randomized Pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS ONE. 2014; 9(4): e91027. doi: 10.1371/journal.pone.0091027

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets vs. low-fat diets on body weight and cardiovascular risk factors: A meta-analysis of randomised con-trolled trials. Br J Nutr. 2016; 115(3): 466-479. doi: 10.1017/ S0007114515004699

Monnier L, Colette C. Glycemic variability: Can we bridge the divide between controversies? Diabetes Care. 2011; 34(4): 1058-1059. doi: 10.2337/dc11-0071

Service FH. Glucose variability. Diabetes. 2013; 62(5): 1398-404. doi: 10.2337/db12-1396

Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH. No relevant relationship between glucose variability and oxida-tive stress in well-regulated type 2 diabetes patients.J Diabetes Sci Technol. 2011; 5(1): 86-92. doi: 10.1177/193229681100500112

Baghurst P. Calculating the mean amplitude of glycemic ex-cursion fromcontinuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther. 2011; 13(3): 296-302. doi: 10.1089/dia.2010.0090

Kusunoki Y, Katsuno T, Nakae R, et al. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring. Diabetes Res Clin Pract. 2015; 108(2): 342-349. doi: 10.1016/j.diabres.2015.01.040

Lin J, Hu FB, Curhan GC. Associations of diet with albumin-uria and kidney function decline. Clin J Am Soc Nephrol. 2010; 5: 836-843. doi: 10.2215/CJN.08001109

Lin J, Fung TT, Hu FB, Curhan GC. Association of dietary patterns with albuminuria and kidney function decline in old-er white women: A subgroup analysis from the nurses’ health study. Am J Kidney Dis. 2011; 57(2): 245-254. doi: 10.1053/j. ajkd.2010.09.027

Tay J, Thompson CH, Luscombe-Marsh ND, et al. Long-term effects of a very low carbohydrate compared with a high carbohydrate diet on renal function in individuals with type 2 di-abetes: A randomized trial. Medicine (Baltimore). 2015; 94(47): e2181. doi: 10.1097/MD.0000000000002181

Brinkworth GD, Buckley JD, Noakes M, Clifton PM. Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs. high-carbohydrate diet. J Am Diet Assoc. 2010; 110: 633-638. doi: 10.1016/j.jada.2009.12.016

Friedman AN, Ogden LG, Foster GD, et al. Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol. 2012; 7: 1103-1111. doi: 10.2215/CJN.11741111

Tirosh A, Golan R, Harman-Boehm I, et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care. 2013; 36: 2225-2232. doi: 10.2337/dc12-1846

Jesudason DR, Pedersen E, Clifton PM. Weight-loss diets in people with type 2 diabetes and renal disease: a randomized con-trolled trial of the effect of different dietary protein amounts. Am J Clin Nutr. 2013; 98: 494-501. doi: 10.3945/ajcn.113.060889

Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum cre-atinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008; 51: 395-406. doi: 10.1053/j.ajkd.2007.11.018

Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604-612. doi: 10.7326/0003-4819-150-9-200905050- 00006

Inker LA, Schmid CH, Tighiouart H, et al. Estimating glo-merular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367(1): 20-29. doi: 10.1056/NEJMoa1114248

Stevens PE, Levin A, for the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Devel-opment Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Im-proving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158: 825-830. doi: 10.7326/0003-4819-158- 11-201306040-00007

Fan L, Inker LA, Rossert J, et al. Glomerular filtration ra-teestimation using cystatin C alone or combined with creatinine as aconfirmatory test. Nephrol Dial Transplant. 2014; 29: 1195- 1203. doi: 10.1093/ndt/gft509

Published

2017-07-12

How to Cite

Hiroshi Bando, Koji Ebe, Tetsuo Muneta, Masahiro Bando, & Yoshikazu Yonei. (2017). Investigation of Uric Acid and Cystatin C on Low-Carbohydrate Diet (LCD). Diabetes Research, 3(2), 31–38. https://doi.org/10.17140/DROJ-3-133